ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3,1,Glucose-6-phosphate dehydrogenase deficiency,Inborn errors of carbohydrate metabolism (excl glucose),Metabolic and nutritional disorders congenital,Cong,N
3,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
4,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
6,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
7,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
9,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
9,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
10,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
10,2,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
10,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
11,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
13,2,Glucose-6-phosphate dehydrogenase deficiency,Inborn errors of carbohydrate metabolism (excl glucose),Metabolic and nutritional disorders congenital,Cong,N
13,3,Headache,Headaches NEC,Headaches,Nerv,N
13,4,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
13,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
14,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,2,Methaemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
15,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
16,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
16,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
16,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
18,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
18,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
18,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
19,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
20,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
21,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,2,Blood smear test abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
21,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
21,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
21,5,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
21,6,Reticulocyte count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
21,7,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
22,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
22,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
23,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
23,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
24,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
24,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
25,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
26,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
27,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
28,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,4,Headache,Headaches NEC,Headaches,Nerv,N
28,5,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
29,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
30,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
31,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
33,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
34,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
35,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
35,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
35,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
35,5,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
36,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
38,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
39,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
39,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
39,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
39,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
40,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
